Medications for Stopping Lactation or Breastfeeding
Cabergoline is the preferred medication for inhibition of lactation with a single 1 mg dose providing effective suppression while having fewer adverse effects than alternatives like bromocriptine. 1, 2
First-Line Medication Option
Cabergoline
- Dosage: 1 mg as a single oral dose within 24 hours after delivery 2
- Mechanism: Dopamine agonist that inhibits prolactin secretion
- Effectiveness: High rate of complete success with time to cessation between 0-1 day 2
- Advantages:
- Once-only dosing (compared to multiple doses for other medications)
- Better tolerated than bromocriptine
- Fewer rebound symptoms
- Long-acting (elimination half-life allows for single dosing) 3
Safety Considerations
Side Effects of Cabergoline
- Common side effects (generally mild and self-limiting):
- Dizziness
- Headache
- Nausea 2
- These side effects can be minimized by taking the medication with food or while lying down 3
Contraindications
- Caution in patients with:
- Should not be administered concurrently with D2-antagonists (phenothiazines, butyrophenones, thioxanthenes, metoclopramide) 1
Alternative Approaches
Non-Pharmacological Methods
- Simple analgesics: Paracetamol can ease discomfort associated with breast engorgement 4
- Supportive measures:
- Wearing a supportive bra (preferable to breast binding which causes more discomfort) 4
- Cold compresses to reduce inflammation and pain
- Without intervention, lactation naturally ceases after 1-2 weeks 4
Medications to Avoid
- Bromocriptine: Contraindicated due to potentially serious cardiovascular adverse effects that are disproportionate to the discomfort they prevent 4, 5
- High-dose estrogens: Unreasonable risk of thromboembolism in the postpartum setting 4
- Diuretics: No proven efficacy for lactation suppression 4
Clinical Decision Algorithm
- Assess necessity: Determine if pharmacological suppression is truly needed (some women may tolerate the temporary discomfort with simple measures)
- If pharmacological suppression is desired:
- Verify no contraindications to cabergoline
- Administer 1 mg oral dose of cabergoline within 24 hours after delivery
- If cabergoline is contraindicated:
- Rely on non-pharmacological measures (supportive bra, cold compresses)
- Use paracetamol for pain management
- Monitor for adverse effects:
- Observe for dizziness, headache, nausea
- Instruct patient to report any unusual symptoms
Important Caveats
- Medications should not be routinely given to women who do not wish to breastfeed without discussing risks and benefits 5
- Women should be informed that breast discomfort, while potentially intense, is temporary and typically resolves within 1-2 weeks 4
- The risks of pharmacological treatments should be carefully weighed against the temporary nature of lactation discomfort 4